Keytruda authorized for sale by Health Canada

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Merck Canada Inc. announced that Keytruda (pembrolizumab) was authorized for sale with conditions by Health Canada.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Login